- Home
- SLXN vs SPRC Comparison
SLXN vs SPRC Comparison
Compare SLXN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- SPRC
- Stock Information
- Founded
- SLXN 2008
- SPRC 2004
- Country
- SLXN Israel
- SPRC Israel
- Employees
- SLXN N/A
- SPRC N/A
- Industry
- SLXN
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SLXN
- SPRC Health Care
- Exchange
- SLXN NYSE
- SPRC Nasdaq
- Market Cap
- SLXN 4.3M
- SPRC 4.8M
- IPO Year
- SLXN N/A
- SPRC N/A
- Fundamental
- Price
- SLXN $0.84
- SPRC $0.45
- Analyst Decision
- SLXN Strong Buy
- SPRC
- Analyst Count
- SLXN 1
- SPRC 0
- Target Price
- SLXN $9.00
- SPRC N/A
- AVG Volume (30 Days)
- SLXN 31.1M
- SPRC 809.4K
- Earning Date
- SLXN 03-04-2025
- SPRC 02-15-2025
- Dividend Yield
- SLXN N/A
- SPRC N/A
- EPS Growth
- SLXN N/A
- SPRC N/A
- EPS
- SLXN N/A
- SPRC N/A
- Revenue
- SLXN N/A
- SPRC $1,747,000.00
- Revenue This Year
- SLXN N/A
- SPRC N/A
- Revenue Next Year
- SLXN N/A
- SPRC N/A
- P/E Ratio
- SLXN N/A
- SPRC N/A
- Revenue Growth
- SLXN N/A
- SPRC N/A
- 52 Week Low
- SLXN $0.21
- SPRC $0.20
- 52 Week High
- SLXN $13.56
- SPRC $4.29
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- SPRC 43.71
- Support Level
- SLXN N/A
- SPRC $0.43
- Resistance Level
- SLXN N/A
- SPRC $0.55
- Average True Range (ATR)
- SLXN 0.00
- SPRC 0.06
- MACD
- SLXN 0.00
- SPRC -0.01
- Stochastic Oscillator
- SLXN 0.00
- SPRC 25.84
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.